Navigation Links
Auxilium Pharmaceuticals, Inc, Announces Second Quarter 2013 Financial Results
Date:8/1/2013

y 47 territories.
  • On July 15, 2013, the Company and Swedish Orphan Biovitrum AB (STO: SOBI) announced a long-term collaboration for the development, supply and commercialization of XIAPEX®  (collagenase clostridium histolyticum), a novel, first-in-class biologic for the treatment of Dupuytren's contracture, in 71 Eurasian and African countries.  In addition, work is on-going to file for approval of XIAPEX for the treatment of Peyronie's disease in the EU. Under the terms of the agreement, Auxilium expects to receive significant tiered double-digit royalties based on sales of XIAPEX in Sobi's territories, which will also cover payment for product supply.  Additionally, Auxilium could receive up to $40 million in potential sales milestone payments from Sobi.
  • In the second quarter of 2013, Auxilium completed enrollment for a 725 patient study with XIAFLEX for the concurrent treatment of multiple palpable cords that, if successful, could allow the Company to seek FDA approval and expansion of the Dupuytren's label.
    Top-line data from this study is now expected by the end of 2013. 
  • On April 29, 2013, Auxilium announced that it had completed the acquisition of Actient Holdings LLC ("Actient"), a private urology specialty therapeutics company, for $585 million in upfront cash plus certain contingent consideration and warrants to purchase Auxilium common stock.
  • Second Quarter 2013 Financial Details 
    Total revenues for the three months ended June 30, 2013 were $100.5 million, an increase of 29% over the $78.2 million recorded in the second quarter of 2012.  This increase in net revenues was due to increases in U.S. sales of XIAFLEX and the addition of the Actient products, which are included in Auxilium results since the closing of the transaction on April 26, 2013.  For the second quarter of 2013, U.S. XIAFLEX net revenues increased by 26% and U.S. Testim net revenues decrea
    '/>"/>

    SOURCE Auxilium Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
    2. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
    3. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
    4. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
    5. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
    6. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
    7. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
    8. Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
    9. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
    10. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
    11. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/3/2015)... 3, 2015  Cyberonics, Inc. (NASDAQ: CYBX ... treatment and management of epilepsy, today announced it will ... March 11, 2015, in Miami . ... Chief Executive Officer, will speak at 1:05 PM Eastern ... chat format, and no formal materials will be presented.  ...
    (Date:3/3/2015)... March 3, 2015  The eleventh annual Tucson Symposium ... the world,s top research scientists, academics, oncologists and pathologists ... and learn about new outcomes in patient treatments that ... Each year Ventana Medical Systems, Inc. (Ventana), ... the Tucson Symposium at the Hilton El Conquistador in ...
    (Date:3/3/2015)... 3, 2015 /CNW/ - ChipCare Corporation, a University of ... for HIV and other infectious and non-communicable diseases ... to bring its first-generation product to market while ... (Photo: http://photos.prnewswire.com/prnh/20150303/179107 ) ... simple, accurate and affordable diagnostic tests makes it ...
    Breaking Medicine Technology:Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium 2ChipCare Closes Oversubscribed $5 Million Series A Financing 2ChipCare Closes Oversubscribed $5 Million Series A Financing 3
    ... 23, 2011 Valeant Pharmaceuticals International, Inc. (the "Company" ... Notice of Intention to make a normal course issuer ... that the TSX has accepted the Notice of Intention. ... to purchase for cancellation, commencing August 25, 2011, 1,000,000 ...
    ... 2011 Bacterin International Holdings, Inc. (NYSE Amex: ... revolutionary bone graft material and antimicrobial coatings for medical applications, ... Annual Global Investment Conference. The conference will be held at ... 11-13, 2011. Bacterin,s chairman and CEO, Guy Cook, ...
    Cached Medicine Technology:Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid 2Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid 3Bacterin International to Present at Rodman & Renshaw Annual Global Investment Conference on September 12, 2011 2
    (Date:3/3/2015)... Introducing 3D Digital Technologies to ... recognized leader in Digital Dentistry. Acute precision in ... dental replicas, leaving no room for error during ... professionals are able to significantly reduce “chair time” ... remarkable quality while reducing labor and material costs ...
    (Date:3/3/2015)... BOCA RATON, Fla - (March 3, 2015) (PRWEB) March ... First Class Vacations, Inc. (FCV), an innovator in the ... next step in his trailblazing expansion plan. To fulfill ... forward with the addition of 400 fun, exciting and ... Raton, Florida headquarters and a news sales center planned ...
    (Date:3/3/2015)... March 03, 2015 According to ... http://www.idataresearch.com ), market saturation has made neurosurgery navigation ... the United States. Unit sales growth moderately increased ... as facilities replace older systems, and as new ... market is very much a replacement and upgrade ...
    (Date:3/3/2015)... (PRWEB) March 03, 2015 eMedEvents, ... and continuing medical education (CME) credit information, has ... for doctors was initially launched in the United ... of its kind in the field of healthcare ... launch of this Denver, Colorado-based start-up company was ...
    (Date:3/3/2015)... 2015 State after state prove ... of probation programs aimed to rehabilitate nonviolent drug ... (tax) cost of incarcerating violators of drug laws, ... alcohol addiction treatment. Governor Bruce Rauner ( R)has ... Illinois' drug and alcohol statewide Department of Alcoholism ...
    Breaking Medicine News(10 mins):Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 2Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 3Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 2Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 3Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 2Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 3Health News:eMedEvents Launches Online Medical Conference, Speaker and CME Platform in India 2Health News:Gov. of Illinois, Bruce Rauner, Suggests Cutting 25 Million for Drug Rehabilitation, Harbor Village Comments 2
    ... 18 ReBuilder,Medical Technologies, Inc. (Pink Sheets: ... world-renowned medical device inventor David B.,Phillips, Ph.D., ... organization and facilitation. (Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO ... many companies are outsourcing customer service to,overseas ...
    ... Prostatitis is a common,problem, yet the antibiotics physicians ... associated with this condition work in only a ... condition have a form called,chronic nonbacterial prostatitis, which ... edition of Harvard Medical School,s Perspectives on Prostate,Disease ...
    ... is the World,s First Accurate Non-Contact Clinical Thermometer, ... Inc., a division of,American Scientific Resources, (ASFX-OTC) today ... the first non-contact clinical,thermometer in the world, now ... Thermofocus 5-in-1, made in Italy and long,recommended by ...
    ... University of Jerusalem have developed a novel approach for ... of providing improved movements of natural or artificial limbs ... , Neuroscientists have long been working towards achieving a ... behavior, and especially between neural activity in the motor ...
    ... A new study from the USC Davis School of ... negative mental or physical health effects as a result ... , The findings, which appeared in the September ... and physical health differences between African-American and white caregivers. ...
    ... Under Bed Nets, NEW YORK, Oct. 18 ... contribute to the distribution of 1.4,million bed nets to ... the Malagasy government, the campaign will ensure that virtually,every ... a bed net. Sumitomo,Chemical donated 110,000 long-lasting insecticide-treated Olyset ...
    Cached Medicine News:Health News:ReBuilder Medical Technologies, Inc. Hires Nurses Exclusively to Provide Customer Support 2Health News:ReBuilder Medical Technologies, Inc. Hires Nurses Exclusively to Provide Customer Support 3Health News:Antibiotics May Not Help Men's Chronic Pelvic Pain: Harvard Doctors Discuss Alternatives 2Health News:Kidz-Med to Launch the Thermofocus(R) 5-in-1 Exclusively at Walgreens Stores Nationwide 2Health News:Kidz-Med to Launch the Thermofocus(R) 5-in-1 Exclusively at Walgreens Stores Nationwide 3Health News:Brain measurements could lead to better devices to move injured or artificial limbs 2Health News:Brain measurements could lead to better devices to move injured or artificial limbs 3Health News:USC study examines effects of caregiving 2Health News:Malaria No More and Sumitomo Chemical Help Protect 1.4 Million Kids from Malaria 2Health News:Malaria No More and Sumitomo Chemical Help Protect 1.4 Million Kids from Malaria 3
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: